Worse, however, was the finding that Tredaptive plus statin therapy resulted in a statistically significant increase in non-fatal adverse events observed, such as diabetic complications, new onset diabetes, GI and musculoskeletal effects.
FORBES: Niacin, Statins And Difficulties Of Drug Discovery